Neutralizing antibodies are a major correlate of protection for many viruses including the
novel coronavirus SARS-CoV-2. Thus, vaccine candidates should potently induce neutralizing …

… André Volland … Ludwig Knabl, Janine Kimpel, Annika Rössler, André Volland, Lisa Pipperger,
Lydia Riepler, Barbara Falkensammer, Wegene Borena & Dorothee von … André Volland …

Protease inhibitors are among the most powerful antiviral drugs. Nirmatrelvir is the first
protease inhibitor specifically developed against the SARS-CoV-2 protease 3CL pro that has …

Members of the Old World Arenaviruses primarily utilize α-dystroglycan (α-DAG1) as a
cellular receptor for infection. Mutations within the glycoprotein (GP) of lymphocytic …

Human papilloma virus (HPV) infections are associated with almost all cervical cancers and
to a lower extend also with anogenital or oropharyngeal cancers. HPV proteins expressed in …

N-chlorotaurine (NCT) a long-lived oxidant generated by leukocytes, can be synthesized
chemically and applied topically as an anti-infective to different body sites, including the lung …

Protease inhibitors are among the most powerful antiviral drugs. However, for SARS-CoV-2
only a small number of protease inhibitors have been identified thus far and there is still a …

SARS-CoV-2 infection ranges from asymptomatic to severe with lingering symptomatology
in some. This prompted investigation of whether or not asymptomatic disease results in …

Rapid molecular surveillance of SARS-CoV-2 S-protein variants leading to immune escape
and/or increased infectivity is of utmost importance. Among global bottlenecks for variant …

Protease inhibitors are among the most powerful antiviral drugs. A first protease inhibitor
against the SARS-CoV-2 protease 3CLpro, Paxlovid (nirmatrelvir / ritonavir), has recently been …